University of Cambridge > > Babraham Seminar > Supramolecular arsenal of adaptive and natural killers

Supramolecular arsenal of adaptive and natural killers

Add to your list(s) Download to your calendar using vCal

  • UserProf. Michael Dustin; Professor of Immunology and Wellcome Principal Research Fellow, Director of Research - Kennedy Institute, University of Oxford
  • ClockFriday 31 July 2020, 13:00-14:00
  • HouseZoom Seminar.

If you have a question about this talk, please contact Bobbie Claxton.

This seminar will be online via zoom

CD8 T cells and natural killer (NK) cells play an important role in defense against viral infection and cancer. Both cell types use multiple cytotoxic pathways to kill infected or deranged host cells and can also directly target bacteria and parasites. In this talk I will discuss three stories related to how CD8 T cells establish cytotoxic of inhibitory immunological synapses. The first story relates to effector mechanisms utilized by CD8 T cells and NK cells with supramolecular assemblies based on 100 nm particles. Which cytotoxic mechanisms are deployed is tactical and basic on what target-associated receptors are present. FAS on targets triggered extracellular vesicles with FasL, whereas 100 nm protein “bombs” with a core of perforin and granzymes and a shell of thrombospondin-1 were deployed when the target expressed ICAM1 . We refer to these protein bombs as supramolecular attack particles, which are made by CD8 T cells and NK cells. Adhesion molecules like ICAM1 and CD58 establish the immunological synapse. I will describe how CD2 contributes to signal amplification in synapses and how CD2 expression is low in TILs in several types of cancer. Finally, I will discuss how malaria parasites use some members of a large family of proteins called RIFI Ns to inhibit attack by NK cells-shifting the activating immune synapse to an inhibitory immune synapse to protect parasitized red blood cells.

Join Zoom Meeting:

Meeting ID: 940 6034 0861 Password: 397600

This talk is part of the Babraham Seminar series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity